| Cover | Mar. 24, 2023 |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Current Report on Form 8-K/A (this “Amendment”) is being filed to amend the Current Report on Form 8-K filed by bioAffinity Technologies, Inc. (the “Company”) on March 24, 2023 (the “Original Form 8-K”). The purpose of this Amendment is to attach an updated press release as Exhibit 99.1, which corrects the URL for the Investor Relations section of the Company’s website. No other changes are being made to the Original Form 8-K or to the original press release attached thereto. |
| Document Period End Date | Mar. 24, 2023 |
| Entity File Number | 001-41463 |
| Entity Registrant Name | BIOAFFINITY TECHNOLOGIES, INC. |
| Entity Central Index Key | 0001712762 |
| Entity Tax Identification Number | 46-5211056 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 22211 W Interstate 10 |
| Entity Address, Address Line Two | Suite 1206 |
| Entity Address, City or Town | San Antonio |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 78257 |
| City Area Code | (210) |
| Local Phone Number | 698-5334 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common Stock, par value $.007 per share | |
| Title of 12(b) Security | Common Stock, par value $.007 per share |
| Trading Symbol | BIAF |
| Security Exchange Name | NASDAQ |
| Tradeable Warrants to purchase Common Stock | |
| Title of 12(b) Security | Tradeable Warrants to purchase Common Stock |
| Trading Symbol | BIAFW |
| Security Exchange Name | NASDAQ |
